328 related articles for article (PubMed ID: 1677569)
1. Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidrug-resistant human breast tumor xenografts in athymic nude mice.
Mimnaugh EG; Fairchild CR; Fruehauf JP; Sinha BK
Biochem Pharmacol; 1991 Jul; 42(2):391-402. PubMed ID: 1677569
[TBL] [Abstract][Full Text] [Related]
2. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
3. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
Mimnaugh EG; Dusre L; Atwell J; Myers CE
Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
Sinha BK; Mimnaugh EG; Rajagopalan S; Myers CE
Cancer Res; 1989 Jul; 49(14):3844-8. PubMed ID: 2544260
[TBL] [Abstract][Full Text] [Related]
5. Modulation of glutathione peroxidase expression by selenium: effect on human MCF-7 breast cancer cell transfectants expressing a cellular glutathione peroxidase cDNA and doxorubicin-resistant MCF-7 cells.
Chu FF; Esworthy RS; Akman S; Doroshow JH
Nucleic Acids Res; 1990 Mar; 18(6):1531-9. PubMed ID: 2158080
[TBL] [Abstract][Full Text] [Related]
6. Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line.
Ivy SP; Tulpule A; Fairchild CR; Averbuch SD; Myers CE; Nebert DW; Baird WM; Cowan KH
J Biol Chem; 1988 Dec; 263(35):19119-25. PubMed ID: 3143724
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
Dusre L; Mimnaugh EG; Myers CE; Sinha BK
Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
[TBL] [Abstract][Full Text] [Related]
9. Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells.
Wells WW; Rocque PA; Xu DP; Meyer EB; Charamella LJ; Dimitrov NV
Free Radic Biol Med; 1995 Apr; 18(4):699-708. PubMed ID: 7750794
[TBL] [Abstract][Full Text] [Related]
10. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
11. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
12. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.
Fairchild CR; Ivy SP; Kao-Shan CS; Whang-Peng J; Rosen N; Israel MA; Melera PW; Cowan KH; Goldsmith ME
Cancer Res; 1987 Oct; 47(19):5141-8. PubMed ID: 2441861
[TBL] [Abstract][Full Text] [Related]
13. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.
Dong Z; Radinsky R; Fan D; Tsan R; Bucana CD; Wilmanns C; Fidler IJ
J Natl Cancer Inst; 1994 Jun; 86(12):913-20. PubMed ID: 7910854
[TBL] [Abstract][Full Text] [Related]
14. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
Vickers PJ; Dickson RB; Shoemaker R; Cowan KH
Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
[TBL] [Abstract][Full Text] [Related]
15. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates.
Poupon MF; Arvelo F; Goguel AF; Bourgeois Y; Jacrot M; Hanania N; Arriagada R; Le Chevalier T
J Natl Cancer Inst; 1993 Dec; 85(24):2023-9. PubMed ID: 7902445
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells.
Ozkan A; Ayhan A; Fiskin K
Cell Biol Toxicol; 2004 Sep; 20(5):261-71. PubMed ID: 15685929
[TBL] [Abstract][Full Text] [Related]
17. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas.
Fairchild CR; Ivy SP; Rushmore T; Lee G; Koo P; Goldsmith ME; Myers CE; Farber E; Cowan KH
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7701-5. PubMed ID: 2890168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]